Literature DB >> 23184442

Ischaemic stroke and thrombolysis: ask the onset time, not the age!

Silvia Cenciarelli1, Tatiana Mazzoli, Stefano Ricci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23184442     DOI： 10.1007/s11739-012-0879-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  7 in total

1.  rt-PA for ischaemic stroke: what will the next question be?

Authors:  Didier Leys; Charlotte Cordonnier
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

2.  Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need?

Authors:  A G Rudd; A Hoffman; R Grant; J T Campbell; D Lowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-25       Impact factor: 10.154

3.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 4.  Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2007-10-04       Impact factor: 7.914

5.  Statistical analysis plan for the third International Stroke Trial (IST-3); part of a 'thread' of reports of the trial.

Authors:  Peter Sandercock; Richard Lindley; Joanna Wardlaw; Will Whiteley; Gordon Murray
Journal:  Int J Stroke       Date:  2012-04       Impact factor: 5.266

6.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

Review 7.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321
  7 in total
  2 in total

1.  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

Authors:  Giorgio Costantino; Gian Marco Podda; Mattia Bonzi; Rodolfo Sbrojavacca
Journal:  Intern Emerg Med       Date:  2013-08-23       Impact factor: 3.397

2.  Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients.

Authors:  Capucine Diard-Detoeuf; Séverine Debiais; Mélanie Imbert; Alexandra Musikas; Marie Gaudron; Emeline Laurent; Bertrand De Toffol; Caroline Hommet; Karl Mondon
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.